Agenda

9:00 – 10:00 am Onsite Check-in and Networking
10:00 – 10:10 am Welcome & Opening Remarks
Summit Co-Chair:
William J. Link, PhD, Managing Director – Versant Ventures
10:10 – 11:15 am Private Ophthalmic Companies Showcase
Private Ophthalmic Companies Showcase (6 minutes each)

Co-Moderators:
Murthy V. Simhambhatla, PhD, Senior Vice President – Abbott Medical Optics
K. Angela Macfarlane, President & CEO – ForSight Labs

11:15 – 11:30 am Networking Break
Hosted By:
Genentech
11:30 am – 12:30 pm Review of the Ophthalmology Innovation Cycle
Innovation cycle overview and financing environment update (10 minutes)
William J. Link, PhD, Managing Director – Versant Ventures

Sometimes things don’t go as planned. Where in the innovation cycle did it go wrong? (5 minutes each)

Panel discussion (30 minutes)
Panelists:
James Mazzo, Operating Partner – Versant Ventures
K. Angela Macfarlane, President & CEO – ForSight Labs
Sabri Markabi, MD, Chief Medical Officer & Senior Vice President R&D – Alcon
Thomas Frinzi, President & CEO – WaveTec Vision Systems

Co-Moderators:
William J. Link, PhD, Managing Director – Versant Ventures
Marguerite McDonald, MD, Ophthalmologist – Ophthalmic Consultants of Long Island

12:30 – 1:30 pm Networking Lunch & Ophthalmology Innovator Award Presentation
Award Recipient:
Mark Forchette, CEO – OptiMedica

Mark Forchette serves as president and CEO of OptiMedica. Forchette has more than two decades of experience in ophthalmic sales, marketing and business unit management. Immediately prior to OptiMedica, he serves as vice president of global marketing and sales for the vitreoretinal business unit of Alcon. In this postion, he led the vitreoretinal unit through a period of substantial portfolio enhancement, infrastructure development and a significant increase in market share. Prior to Alcon, Mr. Forchette was vice president of sales and marketing at Grieshaber & Co. Inc., where he let the privately-held Swiss company’s domestic operations through major infrastructure and revenue expansion

Presented By:
Gil Kliman, MD, Managing Director – InterWest Partners

Hosted By:
Abbott Medical Optics

1:30 – 2:15 pm The Role of OUS Clinical Studies & Commercialization in Ophthalmic Innovation
Panel Discussion
Panelists:
Singapore – Donald Tan, MD, Director – Singapore National Eye Centre
Switzerland – Michael Mrochen, PhD, Founder & CEO – IROC Science to Innovation
Argentina – Roberto Zaldivar, MD, President – Instituto Zaldivar S.A.
Italy – Matteo Piovella, MD, Director – Centro di Microchirurgia Ambulatoriale
Malvina B. Eydelman, MD, Director, Division of Ophthalmic Device Evaluation – FDA
Aron Shapiro, Vice President – Ora

Moderator:
Gil Kliman, MD, Managing Director – InterWest Partners

2:15 – 3:00 pm Dry Eye – Challenges & Opportunities
Market Overview: (5 minutes)
Edward J. Holland, MD, Director of Cornea Services & Professor of Ophthalmology – Cincinnati Eye Institute

Company Presentations: (5 minutes each = 25 mins)
Introduction By:
James Mazzo, Operating Partner – Versant Ventures

Panel Discussion: The role dry eye technologies and therapies do/will play in the ophthalmic practice (15 minutes)
Panelists:
Vance Thompson, MD, Assistant Professor of Ophthalmology – University of South Dakota School of Medicine & Director of Refractive Surgery – Vance Thompson Vision
Roger Steinert, MD, Irving H. Leopold Professor & Chair, Ophthalmology School of Medicine – University of California Irvine & Director – The Gavin Herbert Eye Institute School of Medicine
Eric Donnenfeld, MD, President – ASCRS

Co-Moderators:
James Mazzo, Operating Partner – Versant Ventures
Edward J. Holland, MD, Director of Cornea Services & Professor of Ophthalmology – Cincinnati Eye Institute

3:00 – 3:30 pm Networking Break
Hosted By:
Genentech
3:30 – 4:15 pm Corneal Cross Linking – An Emerging Field
Market Overview: (5 minutes)
Stephen Slade, MD, Surgeon – Slade & Baker Vision Center

Company Presentations: (5 minutes each = 15 minutes)
Introduction By:
George Waring IV, MD, Director of Refractive Surgery – Medical University of South Carolina (MUSC) & Storm Eye Institute & Medical Director – Magill Vision Center

Panel Discussion: Challenges & Opportunities for Cross Linking Technoogies (25 minutes)
Panelists:
William B. Trattler, MD, Director of Cornea – Center For Excellence in Eye Care
A. John Kanellopoulos, MD, Director – LaserVision.GR Institue
Maureen O’Connell, President – O’Connell Regulatory Consultants
Anthony Natale, MD, Venture Partner – Aperture Venture Partners

Co-Moderators:
Stephen Slade, MD, Surgeon – Slade & Baker Vision Center
George Waring IV, MD, Director of Refractive Surgery – Medical University of South Carolina (MUSC), Storm Eye Institute & Medical Director – Magill Vision Center

4:15 – 5:00 pm Industry Perspective on the Topics of the Day
Panelists:
Abbott Medical Optics – Jane E. Rady, Division VP, Business Development
Bausch + Lomb – Calvin W. Roberts, MD, Sr. Vice President & Chief Medical Officer
Shire – Quinton Oswald, President & CEO – Neurotech
Alcon – Laurent Attias, Head, Global Commercial Strategy

Moderator:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures

5:00 – 5:10 pm Closing Remarks
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures
5:10 – 6:30 pm Networking Reception
Hosted By:
Ora